Skip to main content

Animations

MJFF Publications

331 - 340 of 6324 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Sex differences for cognitive decline in progressive supranuclear palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105454
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBAD
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-024-01338-y
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adk1296
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Mechanism of human PINK1 activation at the TOM complex in a reconstituted system
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adn7191
    Citation Count: 18
  • Summary Details
    OPEN
    Title: DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00421-0
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00735-w
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A neurocomputational view of the effects of Parkinson’s disease on speech production
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2024.1383714
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Association of body mass index with rapid eye movement sleep behavior disorder in Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1388131
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Impulse control disorders and use of dopamine agonists in early onset Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1404904
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Basal activity of PINK1 and PRKN in cell models and rodent brain
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2023.2286414
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.